Pancreatic Cancer
Pancreatic Cancer Market Forecasts to 2030 - Global Analysis By Type (Pancreatic Neuroendocrine Tumors and Pancreatic Adenocarcinoma), Treatment Type (Immunotherapy, Surgery, Chemotherapy, Hormone Therapy, Targeted Drug Therapy, Radiation Therapy and Other Treatment Types), Diagnosis, Stage of Cancer, Affected Area, End User and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $2.9 BN |
|
Projected Year Value (2030) |
US $8.1 BN |
|
CAGR (2023 - 2030) |
15.6% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
Asia Pacific |
|
Highest Growing Market |
North America |
According to Stratistics MRC, the Global Pancreatic Cancer Market is accounted for $2.9 billion in 2023 and is expected to reach $8.1 billion by 2030 growing at a CAGR of 15.6% during the forecast period. Pancreatic cancer is a malignant neoplasm affecting the pancreas, a crucial organ located behind the stomach. This type of cancer occurs when cells in the pancreas undergo uncontrolled growth and division, forming a tumor. It can spread rapidly to nearby organs and distant sites in the body, making it challenging to treat. Symptoms of pancreatic cancer may include abdominal pain, weight loss, jaundice, digestive problems, and fatigue.
According to o the America’s Cancer Society for pancreatic cancer, about 64,050 people will be diagnosed with pancreatic cancer in 2023 and estimation of around 50,550 people will die of pancreatic cancer.
Market Dynamics:
Driver:
Rising incidence of pancreatic cancer
There is a rapid increase in the prevalence of cancer cases, and its growth is driven by factors such as an unhealthy diet, physical inactivity, tobacco and alcohol consumption, air pollution, and physical inactivity. The incidence of cancer cases rises dramatically due to the buildup of cancer cases specific to age and the less effective repair mechanisms that become less effective as the person grows older. Furthermore, there are a growing number of chronic infections that are thought to be risk factors for cancer cases, primarily in countries with low or middle incomes. Therefore, rising incidence is a significant factor propelling market demand.
Restraint:
High treatment costs
High treatment costs pose a significant threat to the pancreatic cancer market. Treatment for pancreatic cancer may be expensive and include radiation therapy, chemotherapy, surgery, and supportive care. Patients may find it difficult to afford or obtain treatment due to its high cost, which may negatively impact their capacity to get timely and effective care. However, the financial burden of treatment can deter patients from seeking necessary medical attention or opting for recommended treatment options. This can lead to delays in diagnosis, suboptimal treatment choices, and poorer treatment outcomes.
Opportunity:
Rise in clinical research
The increase in epidemiologic and basic clinical research is leading to improved prevention, diagnosis, and treatment. Researchers are continuously unravelling the complex molecular and genetic mechanisms underlying pancreatic cancer, paving the way for innovative treatment modalities. Moreover, the exploration of new drug targets, biomarkers, and personalized medicine strategies is a testament to the evolving landscape of pancreatic cancer research. Therefore, a rise in clinical research is a good opportunity for pancreatic cancer treatment.
Threat:
Side effects
Pancreatic cancer treatments have various side effects during and after the treatment, depending on the patient. The most common cancer treatment, chemotherapy, works to kill cancerous cells in the pancreas but also eliminates healthy cells from the body, which has a negative impact on health and the recurrence of side effects in patients. Additionally, there are certain adverse effects from radiation therapy used to treat cancer, like skin reddening, nausea, and appetite loss. In rare instances, even diarrhoea is caused by radiation exposure. Therefore, the side effects of pancreatic cancer treatment impede the growth of the market.
Covid-19 Impact
The COVID-19 pandemic has significantly impacted the pancreatic cancer market. The pandemic caused delays in cancer screenings, diagnoses, and treatment plans, among other routine healthcare services. Patients with pancreatic cancer faced hurdles in accessing timely medical care due to restrictions, reallocation of resources, and a shift in healthcare priorities toward managing the pandemic. Moreover, clinical trials and research activities were also affected, which slowed down the progress of new treatment modalities and therapeutic advancements.
The chemotherapy segment is expected to be the largest during the forecast period
The chemotherapy segment is estimated to hold the largest share. Chemotherapy is becoming increasingly common due to benefits like stopping cancer from spreading, killing cancer cells, slowing the growth of the disease, and using strong chemicals to kill rapidly growing cells. Moreover, chemotherapy is used in any stage of pancreatic cancer to kill the cancer cells, and the drugs are administered in cycles with an alternating period of diagnosis and recovery. Additionally, chemotherapy for pancreatic cancer can be given during surgery or in conjunction with radiation therapy.
The clinics segment is expected to have the highest CAGR during the forecast period
The clinics segment is anticipated to have lucrative growth during the forecast period. The primary drivers of the growth of specialty clinics or cancer centers are genuine treatment combined with high-quality services. The availability of clinical staff members is a benefit of specialty clinics because oncologists and medical professionals share the same entity and specialization, and the patient can easily and affordably receive a diagnosis and treatment. Specialty clinics only offer specialized types of medicine, such as cancer centers for cancer patients, making it easier to manage insurance, patient scheduling, and access to the most recent advancements in cancer treatment.
Region with largest share:
Asia Pacific commanded the largest market share during the extrapolated period. The region has a sizable and quickly expanding population, which raises the prevalence of pancreatic cancer cases. The prevalence of risk factors such as smoking, obesity, and diabetes further adds to the disease burden in this region. Furthermore, access to cancer treatment and the quality of healthcare infrastructure have both improved in the Asia-Pacific region. The availability of advanced diagnostic technologies, including imaging modalities and molecular testing, has enhanced the early detection and diagnosis of pancreatic cancer. This has led to improved patient outcomes and an increased demand for diagnostic services in this region.
Region with highest CAGR:
North America is expected to witness profitable growth over the projection period. North America has a high prevalence of pancreatic cancer, making it a crucial region for research, diagnosis, and treatment advancements. Considerable progress has been made in the understanding of the disease and the development of targeted therapies due to the region's strong research infrastructure and funding opportunities. Furthermore, North America has a well-established healthcare system that provides access to specialized healthcare services and advanced treatment options.
Key players in the market
Some of the key players in the Pancreatic Cancer Market include Diffusion Pharmaceuticals, Novartis International AG, Amgen, Inc., Pharmacyte Biotech Inc., Polaris Pharmaceuticals, Inc., Clovis Oncology, OncoGenex Pharmaceuticals Inc., Oncolytics Biotech, Sun BioPharma, Inc., Eli Lilly and Company, Midatech Pharma PLC, F. Hoffmann-La Roche AG and Celgene Corporation.
Key Developments:
In Oct 2023, Sun Pharma and Zydus Life sciences announced that they have entered into a licensing agreement to co-market Desidustat, an oral treatment for anaemia associated with Chronic Kidney Disease (CKD) in India.
In Jan 2022, Novartis announced collaboration with Alnylam to leverage Alnylam’s proven, proprietary siRNA technology to inhibit a target discovered at the Novartis Institutes for Bio Medical Research, potentially leading to development of a treatment designed to promote the re growth of functional liver cells and to provide an alternative to transplantation for patients with liver failure.
Types Covered:
• Pancreatic Neuroendocrine Tumors
• Pancreatic Adenocarcinoma
Treatment Types Covered:
• Immunotherapy
• Surgery
• Chemotherapy
• Hormone Therapy
• Targeted Drug Therapy
• Radiation Therapy
• Other Treatment Types
Diagnosis Covered:
• Computerized Tomography (CT) Scans
• Blood Test
• Positron Emission Tomography (PET) Scans
• Ultrasound
• Magnetic Resonance Imaging (MRI)
• Biopsy
• Other Diagnosis
Stage of Cancers Covered:
• Early Stage
• Locally Advanced
• Metastatic
Affected Areas Covered:
• Endocrine
• Exocrine
End Users Covered:
• Hospitals
• Diagnostic Laboratories
• Research Laboratories
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Pancreatic Cancer Market, By Type
5.1 Introduction
5.2 Pancreatic Neuroendocrine Tumors
5.3 Pancreatic Adenocarcinoma
6 Global Pancreatic Cancer Market, By Treatment Type
6.1 Introduction
6.2 Immunotherapy
6.3 Surgery
6.4 Chemotherapy
6.5 Hormone Therapy
6.6 Targeted Drug Therapy
6.7 Radiation Therapy
6.8 Other Treatment Types
7 Global Pancreatic Cancer Market, By Diagnosis
7.1 Introduction
7.2 Computerized Tomography (CT) Scans
7.3 Blood Test
7.4 Positron Emission Tomography (PET) Scans
7.5 Ultrasound
7.6 Magnetic Resonance Imaging (MRI)
7.7 Biopsy
7.8 Other Diagnosis
8 Global Pancreatic Cancer Market, By Stage of Cancer
8.1 Introduction
8.2 Early Stage
8.3 Locally Advanced
8.4 Metastatic
9 Global Pancreatic Cancer Market, By Affected Areas
9.1 Introduction
9.2 Endocrine
9.3 Exocrine
10 Global Pancreatic Cancer Market, By End User
10.1 Introduction
10.2 Hospitals
10.3 Diagnostic Laboratories
10.4 Research Laboratories
10.5 Other End Users
11 Global Pancreatic Cancer Market, By Geography
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 New Zealand
11.4.6 South Korea
11.4.7 Rest of Asia Pacific
11.5 South America
11.5.1 Argentina
11.5.2 Brazil
11.5.3 Chile
11.5.4 Rest of South America
11.6 Middle East & Africa
11.6.1 Saudi Arabia
11.6.2 UAE
11.6.3 Qatar
11.6.4 South Africa
11.6.5 Rest of Middle East & Africa
12 Key Developments
12.1 Agreements, Partnerships, Collaborations and Joint Ventures
12.2 Acquisitions & Mergers
12.3 New Product Launch
12.4 Expansions
12.5 Other Key Strategies
13 Company Profiling
13.1 Diffusion Pharmaceuticals
13.2 Novartis International AG
13.3 Amgen, Inc.
13.4 Pharmacyte Biotech Inc.
13.5 Polaris Pharmaceuticals, Inc.
13.6 Clovis Oncology
13.7 OncoGenex Pharmaceuticals Inc.
13.8 Oncolytics Biotech
13.9 Sun BioPharma, Inc.
13.10 Eli Lilly and Company
13.11 Midatech Pharma PLC
13.12 F. Hoffmann-La Roche AG
13.13 Celgene Corporation
List of Tables
1 Global Pancreatic Cancer Market Outlook, By Region (2021-2030) ($MN)
2 Global Pancreatic Cancer Market Outlook, By Type (2021-2030) ($MN)
3 Global Pancreatic Cancer Market Outlook, By Pancreatic Neuroendocrine Tumors (2021-2030) ($MN)
4 Global Pancreatic Cancer Market Outlook, By Pancreatic Adenocarcinoma (2021-2030) ($MN)
5 Global Pancreatic Cancer Market Outlook, By Treatment Type (2021-2030) ($MN)
6 Global Pancreatic Cancer Market Outlook, By Immunotherapy (2021-2030) ($MN)
7 Global Pancreatic Cancer Market Outlook, By Surgery (2021-2030) ($MN)
8 Global Pancreatic Cancer Market Outlook, By Chemotherapy (2021-2030) ($MN)
9 Global Pancreatic Cancer Market Outlook, By Hormone Therapy (2021-2030) ($MN)
10 Global Pancreatic Cancer Market Outlook, By Targeted Drug Therapy (2021-2030) ($MN)
11 Global Pancreatic Cancer Market Outlook, By Radiation Therapy (2021-2030) ($MN)
12 Global Pancreatic Cancer Market Outlook, By Other Treatment Types (2021-2030) ($MN)
13 Global Pancreatic Cancer Market Outlook, By Diagnosis (2021-2030) ($MN)
14 Global Pancreatic Cancer Market Outlook, By Computerized Tomography (CT) Scans (2021-2030) ($MN)
15 Global Pancreatic Cancer Market Outlook, By Blood Test (2021-2030) ($MN)
16 Global Pancreatic Cancer Market Outlook, By Positron Emission Tomography (PET) Scans (2021-2030) ($MN)
17 Global Pancreatic Cancer Market Outlook, By Ultrasound (2021-2030) ($MN)
18 Global Pancreatic Cancer Market Outlook, By Magnetic Resonance Imaging (MRI) (2021-2030) ($MN)
19 Global Pancreatic Cancer Market Outlook, By Biopsy (2021-2030) ($MN)
20 Global Pancreatic Cancer Market Outlook, By Other Diagnosis (2021-2030) ($MN)
21 Global Pancreatic Cancer Market Outlook, By Stage of Cancer (2021-2030) ($MN)
22 Global Pancreatic Cancer Market Outlook, By Early Stage (2021-2030) ($MN)
23 Global Pancreatic Cancer Market Outlook, By Locally Advanced (2021-2030) ($MN)
24 Global Pancreatic Cancer Market Outlook, By Metastatic (2021-2030) ($MN)
25 Global Pancreatic Cancer Market Outlook, By Affected Areas (2021-2030) ($MN)
26 Global Pancreatic Cancer Market Outlook, By Endocrine (2021-2030) ($MN)
27 Global Pancreatic Cancer Market Outlook, By Exocrine (2021-2030) ($MN)
28 Global Pancreatic Cancer Market Outlook, By End User (2021-2030) ($MN)
29 Global Pancreatic Cancer Market Outlook, By Hospitals (2021-2030) ($MN)
30 Global Pancreatic Cancer Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
31 Global Pancreatic Cancer Market Outlook, By Research Laboratories (2021-2030) ($MN)
32 Global Pancreatic Cancer Market Outlook, By Other End Users (2021-2030) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
